Literature DB >> 20569587

Angioplasty of an idiopathic intracranial arterial stenosis.

K F Layton1, D F Kallmes, H J Cloft.   

Abstract

SUMMARY: Treatment of symptomatic intracranial atherosclerotic stenosis usually involves maximizing medical therapy. In patients with medically refractory symptoms despite maximum pharmacologic therapy, intracranial angioplasty and/or stenting has become an accepted treatment option. The use of percutaneous transluminal angioplasty (PTA) for idiopathic intracranial stenoses has not been reported to date.We describe a case of idiopathic intracranial stenosis which was refractory to medical therapy and was successfully treated with percutaneous transluminal angioplasty. The presenting symptoms included multiple episodes of aphasia and right-sided weakness as well as a left basal ganglia infarct. The patient underwent treatment with two intracranial angioplasty procedures. There was a recurrence of the stenosis and symptoms following the first procedure. However, after a second treatment with a slightly larger balloon, flow in the MCA normalized. Furthermore, the symptoms attributed to her MCA stenosis had essentially resolved. This case suggests that patients with medically refractory idiopathic intracranial stenosis can be successfully treated with percutaneous transluminal angioplasty.

Entities:  

Year:  2007        PMID: 20569587      PMCID: PMC3354600          DOI: 10.1177/159101990601200403

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  10 in total

1.  Outcome of angioplasty for atherosclerotic intracranial stenosis.

Authors:  M P Marks; M Marcellus; A M Norbash; G K Steinberg; D Tong; G W Albers
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology.

Authors:  Randall T Higashida; Philip M Meyers; John J Connors; David Sacks; Charles M Strother; John D Barr; Joan C Wojak; Gary R Duckwiler
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 3.  Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine.

Authors:  Brian L Hoh; Christopher S Ogilvy
Journal:  Neurosurg Clin N Am       Date:  2005-07       Impact factor: 2.509

4.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Scott E Kasner; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

5.  Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.

Authors:  V N Thijs; G W Albers
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

6.  Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis.

Authors:  A Alazzaz; J Thornton; V A Aletich; G M Debrun; J I Ausman; F Charbel
Journal:  Arch Neurol       Date:  2000-11

7.  Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan).

Authors:  H Henkes; E Miloslavski; S Lowens; J Reinartz; T Liebig; D Kühne
Journal:  Neuroradiology       Date:  2005-03-15       Impact factor: 2.804

8.  Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

9.  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

Authors: 
Journal:  Stroke       Date:  2004-04-22       Impact factor: 7.914

10.  Atherosclerotic disease of the middle cerebral artery.

Authors:  J Bogousslavsky; H J Barnett; A J Fox; V C Hachinski; W Taylor
Journal:  Stroke       Date:  1986 Nov-Dec       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.